These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 6748051)

  • 1. Yeast opsonization and phagocytosis studied by a visual assay and measurement of neutrophil chemiluminescence.
    Vernon J; Kemp AS; Van Asperen PP; Worsdall P; Roy LP
    J Clin Lab Immunol; 1984 Jun; 14(2):93-7. PubMed ID: 6748051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor affecting the in vitro assessment of opsonization: a study of the kinetics of opsonization using the technique of phagocytic chemiluminescence.
    Williams AJ; Hastings MJ; Easmon CS; Cole PJ
    Immunology; 1980 Dec; 41(4):903-11. PubMed ID: 7007217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of C3 levels on yeast opsonization by normal and pathological sera: identification of a complement independent opsonin.
    Kerr MA; Falconer JS; Bashey A; Beck JS
    Clin Exp Immunol; 1983 Dec; 54(3):793-800. PubMed ID: 6652976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of C3b/C3bi opsonization and chemiluminescence with selected yeasts and bacteria using sera of different opsonic potential.
    Turner MW; Grant C; Seymour ND; Harvey B; Levinsky RJ
    Immunology; 1986 May; 58(1):111-5. PubMed ID: 3519441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new semiquantitative radiometric opsonin assay. Selective measurement of opsonizing capacity of the alternative pathway.
    Yamamura M; Valdimarsson H
    Immunology; 1978 Apr; 34(4):689-94. PubMed ID: 363601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective yeast opsonization and C2 deficiency in atopic patients.
    Turner MW; Mowbray JF; Harvey BA; Brostoff J; Wells RS; Soothill JF
    Clin Exp Immunol; 1978 Nov; 34(2):253-9. PubMed ID: 737910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of anti-human neutrophil antibodies in vitro. Quantitative studies.
    Boxer LA; Stossel TP
    J Clin Invest; 1974 Jun; 53(6):1534-45. PubMed ID: 4208468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neutrophil chemiluminescence in pneumoconiosis].
    Saburi Y; Kumae T; Nasu M; Itoga T; Nagato H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jan; 27(1):57-63. PubMed ID: 2747060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Defects in opsonization activity of the serum of patients with chronic arthritis].
    Böhm U; Merétey K; Seszták M; Hodinka L; Koó E; Zahumenszky Z
    Z Rheumatol; 1988; 47(3):161-5. PubMed ID: 3213263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphonuclear neutrophil iodination response as an estimate of defective yeast opsonization.
    Roberton DM; Dhanjal NK; Levinsky RJ; Mowbray JF; Turner MW
    Clin Exp Immunol; 1981 Jan; 43(1):208-14. PubMed ID: 7018758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera.
    Håkansson L; Hällgren R; Venge P
    Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opsonization of mucoid and non-mucoid Pseudomonas aeruginosa by serum from patients with cystic fibrosis assessed by a chemiluminescence assay.
    LeBlanc CM; Bortolussi R; Issekutz AC; Gillespie T
    Clin Invest Med; 1982; 5(2-3):125-8. PubMed ID: 6811181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of the serum defect in yeast opsonization in children with fulminant hepatic failure (FHF).
    Larcher VF; Wyke RJ; Mowat AP; Williams R
    Clin Exp Immunol; 1981 Nov; 46(2):406-11. PubMed ID: 7039888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the opsonic requirements for phagocytosis of Streptococcus pneumoniae serotypes VII, XIV, and XIX by chemiluminescence assay.
    Matthay KK; Mentzer WC; Wara DW; Preisler HK; Lameris NB; Ammann AJ
    Infect Immun; 1981 Jan; 31(1):228-35. PubMed ID: 7216447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of C3b deposition on yeast surfaces by sera of known opsonic potential.
    Turner MW; Mowbray JF; Roberton DR
    Clin Exp Immunol; 1981 Nov; 46(2):412-9. PubMed ID: 7039889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opsonization of yeast cells with equine iC3b, C3b, and IgG.
    Gröndahl G; Johannisson A; Jensen-Waern M; Nilsson Ekdahl K
    Vet Immunol Immunopathol; 2001 Aug; 80(3-4):209-23. PubMed ID: 11457475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired opsonization by serum from patients with chronic liver disease.
    Wyke RJ; Rajkovic IA; Williams R
    Clin Exp Immunol; 1983 Jan; 51(1):91-8. PubMed ID: 6339126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opsonization of yeast by human serum IgA anti-mannan antibodies and phagocytosis by human polymorphonuclear leucocytes.
    Yeaman GR; Kerr MA
    Clin Exp Immunol; 1987 Apr; 68(1):200-8. PubMed ID: 3308208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of nonspecific (alternative pathway) opsonic activity by neutrophil chemiluminescence.
    Hill HR; Hogan NA; Bale JF; Hemming VG
    Int Arch Allergy Appl Immunol; 1977; 53(6):490-7. PubMed ID: 405330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.